Dr. Aramis Odysseus: Large Chromosomal Rearrangements yield biomarkers to distinguish low-risk from intermediate- and high-risk Prostate Cancer. These biomarkers could be used to guide treatment for prostate cancer.

05 January, 2019

Large Chromosomal Rearrangements yield biomarkers to distinguish low-risk from intermediate- and high-risk Prostate Cancer. These biomarkers could be used to guide treatment for prostate cancer.

See the source article by following the link below:
Large Chromosomal Rearrangements yield biomarkers to distinguish low-risk from intermediate- and high-risk Prostate Cancer. These biomarkers could be used to guide treatment for prostate cancer.

No comments:

Subscribe to: Post Comments (Atom)